“The outlook revision reflects our view of BCH’s challenged operations over the past several years, including very poor operating margins in fiscal 2015,” said S&P credit analyst Allison Bretz.
S&P also affirmed the “AA+/A-1” rating on BCH’s series 2000 revenue bonds.
More articles on healthcare finance:
Covenant Health taps Cerner for integrated RCM platform
Medicare’s top 20 costliest drugs
Hospital cost, quality ranking site aims to help employers manage costs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
